词条 | Lugol's iodine | ||||||||||||||||||||||||||||
释义 |
| drug_name = | INN = | type = | IUPAC_name = | image = J_crow's_lugol's_iodine_2.jpg | alt = | caption = | synonyms = Potassium triiodide, Lugol's solution, aqueous iodine, strong iodine solution[1] | pronounce = | tradename = | Drugs.com = {{Drugs.com|monograph|strong-iodine-solution}} | MedlinePlus = | licence_EU = | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_US = | pregnancy_category = | routes_of_administration = topical, by mouth | legal_AU = | legal_AU_comment = | legal_CA = | legal_DE = | legal_NZ = | legal_UK = | legal_US = | legal_UN = | legal_status = | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = | duration_of_action = | excretion = | CAS_number = 12298-68-9 | class = | ATCvet = | ATC_prefix = | ATC_suffix = | PubChem = | DrugBank = | chemical_formula = I3K | molecular_weight = 419.812 }}Lugol's iodine, also known as aqueous iodine and strong iodine solution, is a solution of potassium iodide with iodine in water.[1] It is a medication and disinfectant used for a number of purposes.[2][4] Taken by mouth it is used to treat thyrotoxicosis until surgery can be carried out, protect the thyroid gland from radioactive iodine, and to treat iodine deficiency.[4][3] When applied to the cervix it is used to help in screening for cervical cancer.[4] As a disinfectant it may be applied to small wounds such as a needle stick injury.[2] A small amount may also be used for emergency disinfection of drinking water.[5] Side effects may include allergic reactions, headache, vomiting, and inflammation of the whites of the eyes.[4][1] Long term use may result in trouble sleeping and depression.[4] It should not typically be used during pregnancy or breastfeeding.[6] Lugol's iodine is a liquid made up of two parts potassium iodide for every one part elemental iodine in water.[14] Lugol's iodine was first made in 1829 by the French physician Jean Lugol.[5][7] It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[8] Lugol's iodine is available as a generic medication and over the counter.[9] In the United Kingdom the NHS pays 9.57 pounds per 500 ml of solution.[6] Lugol's solution is available in different strengths of iodine. Large volumes of concentrations more than 2.2% may be subject to regulation.[10] UsesMedical usesPreoperative administration of Lugol's solution decreases intraoperative blood loss during thyroidectomy in patients with Graves' disease.[11] However, it appears ineffective in patients who are already euthyroid on anti-thyroid drugs and levothyroxine.[12]
Science
Side effectsBecause it contains free iodine, Lugol's solution at 2% or 5% concentration without dilution is irritating and destructive to mucosa, such as the lining of the esophagus and stomach. Doses of 10 mL of undiluted 5% solution have been reported to cause gastric lesions when used in endoscopy.[14] The LD50 for 5% Iodine is 14,000 mg/kg (14 g/kg) [Rat] and 22,000 mg/kg (22 g/kg) [Mouse].[15] The World Health Organization classifies substances taken orally with an LD50 of 5–50 mg/kg as the second highest toxicity class, Class Ib (Highly Hazardous).[16] The Global Harmonized System of Classification and Labeling of Chemicals categorizes this as Category 2 with a hazard statement “Fatal if swallowed”.[17] Potassium Iodide is not considered hazardous.[18] Mechanism of actionThese uses are possible since the solution is a source of effectively free elemental iodine, which is readily generated from the equilibrium between elemental iodine molecules and polyiodide ions in the solution. HistoryIt was historically used as a first line treatment for hyperthyroidism, as the administration of pharmacologic amounts of iodine leads to temporary inhibition of iodine organification in the thyroid gland, a phenomenon called the Wolff-Chaikoff effect. However it is not used to treat certain autoimmune causes of thyroid disease as iodine-induced blockade of iodine organification may result in hypothyroidism. They are not considered as a first line therapy because of possible induction of resistant hyperthyroidism but may be considered as an adjuvant therapy when used together with other hyperthyroidism medications. Lugol's iodine has been used traditionally to replenish iodine deficiency. Because of its wide availability as a drinking-water decontaminant, and high content of potassium iodide, emergency use of it was at first recommended to the Polish government in 1986, after the Chernobyl disaster to replace and block any intake of radioactive {{chem|link=Iodine-131|131|I}}, even though it was known to be a non-optimal agent, due to its somewhat toxic free-iodine content.[19] Other sources state that pure potassium iodide solution in water (SSKI) was eventually used for most of the thyroid protection after this accident.[20] There is "strong scientific evidence" for potassium iodide thyroid protection to help prevent thyroid cancer. Potassium iodide does not provide immediate protection but can be a component of a general strategy in a radiation emergency.[21]{{failed verification|date=September 2017}} Historically, Lugol's iodine solution has been widely available and used for a number of health problems with some precautions.[22] Lugol's is sometimes prescribed in a variety of alternative medical treatments.[23][24] Only since the end of the Cold War has the compound become subject to national regulation in the English-speaking world.{{citation needed|date=February 2016}} Society and cultureRegulationUntil 2007, in the United States, Lugol's solution was unregulated and available over the counter as a general reagent, an antiseptic, a preservative,[25] or as a medicament for human or veterinary application. Since August 1, 2007, the DEA regulates all iodine solutions containing greater than 2.2% elemental iodine as a List I precursor because they may potentially be used in the illicit production of methamphetamine.[26] Transactions of up to one fluid ounce (30 ml) of Lugol's solution are exempt from this regulation. Formula and manufacture
Lugol's is available in various strengths from 1% to slightly less than 13% iodine (wt/v). The most commonly-used 15% solution consists of 5% (wt/v) elemental iodine (I2) and 10% (wt/v) potassium iodide (KI) mixed in distilled water, and has a total iodine content of 126.5 mg/mL. The iodide combines with elemental iodine to form a high concentration of potassium triiodide (KI3) solution. Lugol's solution is commonly available in different potencies of 1%, 2% (2.2%), 5% or 10% iodine. Due to the chemical potency of the solution, concentrations more than 2.2% may be subject to national regulation.[27][28][29] The most commonly used 15% solution consists of 5% (wt/v) iodine ({{chem|I|2}}) and 10% (wt/v) potassium iodide (KI) mixed in distilled water and has a total iodine content of 126.5 mg/mL. The 15% solution thus has a total iodine content of 6.32 mg per drop of 0.05 mL; the 2% solution has 0.84 mg total iodine content per drop. Potassium iodide renders the elementary iodine soluble in water through the formation of the triiodide ({{chem|I|3|-}}) ion. It is not to be confused with tincture of iodine solutions, which consist of elemental iodine, and iodide salts dissolved in water and alcohol. Lugol's solution contains no alcohol. Other names for Lugol's solution are {{chem|I|2|KI}} (iodine-potassium iodide); Markodine, Strong solution (Systemic); and Aqueous Iodine Solution BP. In the United Kingdom the NHS pays 9.57 pounds per 500 ml of solution.[6] See alsoIodine antiseptics
Reagents
References1. ^{{cite book|last1=Kaiho|first1=Tatsuo|title=Iodine Chemistry and Applications|date=2014|publisher=John Wiley & Sons|isbn=9781118466292|page=55|url=https://books.google.com/books?id=WabCBwAAQBAJ&pg=PA55|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170918190501/https://books.google.com/books?id=WabCBwAAQBAJ&pg=PA55|archivedate=2017-09-18|df=}} 2. ^1 {{cite book|last1=Block|first1=Seymour Stanton|title=Disinfection, Sterilization, and Preservation|date=2001|publisher=Lippincott Williams & Wilkins|isbn=9780683307405|page=177|url=https://books.google.ca/books?id=3f-kPJ17_TYC&pg=PA177|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170113125624/https://books.google.ca/books?id=3f-kPJ17_TYC&pg=PA177|archivedate=2017-01-13|df=}} 3. ^{{cite book|title=Lugol's solution Drug Information, Professional|date=1994|url=https://www.drugs.com/mmx/lugol-s-solution.html|accessdate=11 January 2017|deadurl=no|archiveurl=https://web.archive.org/web/20170113064908/https://www.drugs.com/mmx/lugol-s-solution.html|archivedate=13 January 2017|df=}} 4. ^{{cite journal|last1=Fokom-Domgue|first1=J|last2=Combescure|first2=C|last3=Fokom-Defo|first3=V|last4=Tebeu|first4=PM|last5=Vassilakos|first5=P|last6=Kengne|first6=AP|last7=Petignat|first7=P|title=Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.|journal=BMJ (Clinical research ed.)|date=3 July 2015|volume=351|pages=h3084|pmid=26142020|doi=10.1136/bmj.h3084|pmc=4490835}} 5. ^1 {{cite book|last1=Preedy|first1=Victor R.|last2=Burrow|first2=Gerard N.|last3=Watson|first3=Ronald Ross|title=Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects|date=2009|publisher=Academic Press|isbn=9780080920863|page=135|url=https://books.google.ca/books?id=7v7g5XoCQQwC&pg=PA135|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170812100039/https://books.google.ca/books?id=7v7g5XoCQQwC&pg=PA135|archivedate=2017-08-12|df=}} 6. ^1 2 3 4 5 6 {{cite book|title=British national formulary : BNF 69|date=2015|publisher=British Medical Association|isbn=9780857111562|page=493|edition=69}} 7. ^1 {{cite book|last1=Sneader|first1=Walter|title=Drug Discovery: A History|date=2005|publisher=John Wiley & Sons|isbn=9780471899792|page=67|url=https://books.google.ca/books?id=Cb6BOkj9fK4C&pg=PA67|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170826071343/https://books.google.ca/books?id=Cb6BOkj9fK4C&pg=PA67|archivedate=2017-08-26|df=}} 8. ^{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/20th_EML2017_FINAL_amendedAug2017.pdf?ua=1|page=50|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}} 9. ^1 2 {{cite web|title=Strong Iodine Solution|url=https://www.drugs.com/monograph/strong-iodine-solution.html|publisher=The American Society of Health-System Pharmacists|accessdate=8 January 2017|deadurl=no|archiveurl=https://web.archive.org/web/20170113074729/https://www.drugs.com/monograph/strong-iodine-solution.html|archivedate=13 January 2017|df=}} 10. ^{{cite web|accessdate=2017-08-26|title=Final Rule: Changes in the Regulation of Iodine Crystals and Chemical Mixtures Containing Over 2.2 Percent Iodine|url=http://www.deadiversion.usdoj.gov/fed_regs/rules/2007/fr0702.htm|date=13 September 2007|deadurl=bot: unknown|archiveurl=https://web.archive.org/web/20070913074919/http://www.deadiversion.usdoj.gov/fed_regs/rules/2007/fr0702.htm|archivedate=13 September 2007|df=}} 11. ^{{cite journal |vauthors=Erbil Y, Ozluk Y, Giriş M, etal |title=Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease |journal=J. Clin. Endocrinol. Metab. |volume=92 |issue=6 |pages=2182–9 |date=June 2007 |pmid=17389702 |doi=10.1210/jc.2007-0229 |url=}} 12. ^{{cite journal |vauthors=Kaur S, Parr JH, Ramsay ID, Hennebry TM, Jarvis KJ, Lester E |title=Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine |journal=Ann R Coll Surg Engl |volume=70 |issue=3 |pages=123–7 |date=May 1988 |pmid=2457351 |pmc=2498739 |doi= |url=}} 13. ^Han, J. Changes in Gingival Dimensions Following Connective Tissue Grafts for Root Coverage: Comparison of Two Procedures. J Perio 2008;79:1346-1354. 14. ^{{cite journal |authors=Sreedharan|date=June 2005 |title=Acute toxic gastric mucosal damage induced by Lugol’s iodine spray during chromoendoscopy |work=Gut |volume= 54 |issue=6 |pages=886–887 |doi=10.1136/gut.2004.061739|display-authors=etal |pmid=15888800 |pmc=1774547}} 15. ^{{cite web |title= Material Safety Data Sheet Iodine Solution, 5% MSDS |url= http://www.sciencelab.com/msds.php?msdsId=9924378 |accessdate= 2016-09-29 |deadurl= no |archiveurl= https://web.archive.org/web/20161206074306/http://www.sciencelab.com/msds.php?msdsId=9924378 |archivedate= 2016-12-06 |df= }} 16. ^{{citation |title= The WHO Recommended Classification of Pesticides by Hazard |author= International Programme on Chemical Safety |publisher= World Health Organization |url= http://www.who.int/ipcs/publications/pesticides_hazard_2009.pdf?ua=1 |year= 2009 |accessdate= 2016-09-28 |page= 5 |deadurl= no |archiveurl= https://web.archive.org/web/20170510071955/http://www.who.int/ipcs/publications/pesticides_hazard_2009.pdf?ua=1 |archivedate= 2017-05-10 |df= }} 17. ^{{citation |title= A Guide to The Globally Harmonized System of Classification and Labeling of Chemicals (GHS) |publisher= US Occupational Safety and Health Administration (OSHA) |url= https://www.osha.gov/dsg/hazcom/ghsguideoct05.pdf |accessdate= 2016-09-28 |page= 42 |deadurl= no |archiveurl= https://web.archive.org/web/20161203012935/https://www.osha.gov/dsg/hazcom/ghsguideoct05.pdf |archivedate= 2016-12-03 |df= }} 18. ^Esciencelabs.com {{webarchive |url=https://web.archive.org/web/20140303214220/http://www.esciencelabs.com/files/andrea.rex/Iodine_Potassium_Iodide.pdf |date=March 3, 2014 }} 19. ^{{cite web |url=http://www.wonuc.org/xfiles/chern_02.html |archive-url=https://web.archive.org/web/20050302210725/http://www.wonuc.org/xfiles/chern_02.html |dead-url=yes |archive-date=2 March 2005 |title=Chernobyl: the Biggest BLUFF of the 20th Century |last=Rotkiewicz |first=Marcin |author2=Henryk Suchar |author3=Ryszard Kamiñski |date=14 January 2001 |work= |publisher=Polish weekly Wprost |pages=no 2 |doi= |accessdate=2008-06-18 |df= }} 20. ^{{cite web |url=http://www.birdflumanual.com/resources/Self_Defense/files/Guidance%20for%20use%20of%20KI%20for%20nuclear%20emergency%20USG.pdf |title=Archived copy |accessdate=2010-01-12 |deadurl=yes |archiveurl=https://web.archive.org/web/20110910170031/http://www.birdflumanual.com/resources/Self_Defense/files/Guidance%20for%20use%20of%20KI%20for%20nuclear%20emergency%20USG.pdf |archivedate=2011-09-10 |df= }} US FDA, "Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies," U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); December, 2001. 21. ^[https://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-iodine.html "Iodine."] {{webarchive|url=https://web.archive.org/web/20100804040405/http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-iodine.html |date=2010-08-04 }} MedlinePlus. 22. ^Drugs.com, [https://www.drugs.com/cons/Lugol_s_solution.html "Lugol's Solution"] {{webarchive|url=https://web.archive.org/web/20051125111859/http://www.drugs.com/cons/Lugol_s_solution.html |date=2005-11-25 }} 23. ^Optimox.com, "Iodine" {{webarchive|url=https://web.archive.org/web/20060506052045/http://www.optimox.com/pics/Iodine/IOD-05/IOD_05.html |date=2006-05-06 }} 24. ^Jcrows.com, "Iodine" {{webarchive|url=https://web.archive.org/web/20070113183458/http://jcrows.com/iodine.html |date=2007-01-13 }} 25. ^{{cite journal | last1 = Hawkins | display-authors = etal | title = Change in cyanobacterial biovolume due to preservation by Lugol's Iodine |year= 2005 | journal = Harmful Algae | volume = 4 | issue = 6| pages = 1033–1043 | doi=10.1016/j.hal.2005.03.001}} 26. ^US DEA, "Final Rule: Changes in the Regulation of Iodine Crystals and Chemical Mixtures Containing Over 2.2 Percent Iodine" {{webarchive|url=https://web.archive.org/web/20070913074919/http://www.deadiversion.usdoj.gov/fed_regs/rules/2007/fr0702.htm |date=2007-09-13 }} (July 2, 2007) Federal Register, Volume 72, Number 126 (FR Doc E7-12736) 27. ^US FDA 1 {{webarchive|url=https://web.archive.org/web/20070913074919/http://www.deadiversion.usdoj.gov/fed_regs/rules/2007/fr0702.htm |date=2007-09-13 }} 28. ^US FDA 2 {{webarchive|url=https://web.archive.org/web/20160306222421/http://www.deadiversion.usdoj.gov/chem_prog/iodine_reg_ltr050108.pdf |date=2016-03-06 }} 29. ^Article {{webarchive|url=https://web.archive.org/web/20160803204831/http://hardydiagnostics.com/articles/iodine-regulations.pdf |date=2016-08-03 }} 6 : Antiseptics|Disinfectants|Staining dyes|Iodine|Chemical tests|RTT |
||||||||||||||||||||||||||||
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。